MapLight Therapeutics reported total assets of $368.35M and total liabilities of $20.05M for the quarter ended Jun 2026, up 169.0% year over year. This balance sheet covers 6 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2024 | Dec2024 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|
| Accumulated Depreciation | 2.08M | 2.50M | 2.64M | |||
| Assets | ||||||
| Current Assets | ||||||
| Cash & EquivalentsCash & Equiv. | 38.25M | 227.20M | 46.73M | 71.63M | ||
| Prepaid Assets | 5.81M | 18.14M | 19.57M | 14.06M | ||
| Current Assets | 114.60M | 245.31M | 324.67M | 318.79M | ||
| Non-Current Assets | ||||||
| Property, Plant & Equipment (Net) | 1.21M | 0.86M | 1.09M | 0.83M | ||
| Long-Term Investments | 11.38M | 147.99M | 46.62M | |||
| Other Non-Current Assets | 3.17M | 5.14M | 0.21M | 0.24M | ||
| Non-Current Assets | 22.31M | 11.92M | 154.84M | 49.56M | ||
| Assets | 136.92M | 257.22M | 479.51M | 368.35M | ||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payables | 1.91M | 2.45M | 3.29M | 2.05M | ||
| Payables | 1.91M | 2.45M | 3.29M | 2.05M | ||
| Accumulated Expenses | 9.99M | 14.05M | 12.05M | 16.01M | ||
| Other Accumulated Expenses | 1.56M | 2.13M | 0.52M | 1.14M | ||
| Current Leases | 0.78M | 0.86M | 0.89M | 1.23M | ||
| Current Deferred Revenue | 3.24M | 1.21M | ||||
| Total Current Liabilities | 15.92M | 18.56M | 16.23M | 19.29M | ||
| Non-Current Liabilities | ||||||
| Preferred Stock Liabilities | 224.99M | 224.99M | 224.99M | 224.99M | ||
| Operating Leases | 5.80M | 5.14M | 4.91M | 0.76M | ||
| Total Non-Current Liabilities | 5.80M | 5.14M | ||||
| Total Liabilities | 172.37M | 21.72M | 245.06M | 23.71M | 21.14M | 20.05M |
| Shareholder's Equity | ||||||
| Common Equity | -172.37M | -193.63M | -245.06M | -274.18M | 458.37M | 348.30M |
| Liabilities and Shareholders Equity | 136.92M | 257.22M | 479.51M | 368.35M | ||
| Retained Earnings | -199.37M | -281.00M | -360.52M | -481.40M | ||
| Treasury Shares | 147.33M | 147.33M | 147.33M | 210.03M |